CN103040828B - R-1132 and preparation method thereof - Google Patents

R-1132 and preparation method thereof Download PDF

Info

Publication number
CN103040828B
CN103040828B CN201310003871.4A CN201310003871A CN103040828B CN 103040828 B CN103040828 B CN 103040828B CN 201310003871 A CN201310003871 A CN 201310003871A CN 103040828 B CN103040828 B CN 103040828B
Authority
CN
China
Prior art keywords
granulate
starch
minutes
ethanol
lactose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310003871.4A
Other languages
Chinese (zh)
Other versions
CN103040828A (en
Inventor
王苏南
汤金春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd
Original Assignee
CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd filed Critical CHANGZHOU KANGPU PHARMACEUTICAL Co Ltd
Priority to CN201310003871.4A priority Critical patent/CN103040828B/en
Publication of CN103040828A publication Critical patent/CN103040828A/en
Application granted granted Critical
Publication of CN103040828B publication Critical patent/CN103040828B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of R-1132 preparation prescription, technique, preparation prescription every ten thousand Central Plains supplementary product kinds and consumption: diphenoxylate hydrochloride 25g, atropine sulfate 0.25g, starch 152-168g, lactose 522.5-577.5g, calcium hydrogen phosphate 47.5-52.5g, 40%(ml/ml) ethanol 76-84g, magnesium stearate 6.65-7.35g.R-1132 of the present invention has good dissolution and content uniformity.

Description

R-1132 and preparation method thereof
Technical field
The present invention relates to R-1132 and preparation method thereof.
Background technology
The hydrochloric diphenoxylate 2.5mg of the every sheet of R-1132, atropine sulfate 25 μ g, for acute and chronic functional diarrhea and chronic enteritis.Diphenoxylate can directly act on intestinal smooth muscle, by suppressing intestinal mucosa sensor, eliminate the wriggling reflection of local mucosa and weaken enterokinesia, the segmental that simultaneously can increase intestinal is shunk, intestinal contents is made to pass through to postpone, being conducive to the absorption of enteral moisture, showing stronger anti-diarrhea effect, is functional diarrhea specific drug.But existing R-1132 dissolution difference difference is large, it is also often comparatively large that ordinary tablet is less than 80%, A+1.8S, and because principal agent atropine content is low, uniformity of dosage units is undesirable.
Summary of the invention
The present invention will solve the technical problem that existing R-1132 dissolution is little, uniformity of dosage units is undesirable.
R-1132 prescription provided by the invention every ten thousand Central Plains supplementary product kinds and consumption: diphenoxylate hydrochloride 25g, atropine sulfate 0.25g, starch 152-168g, lactose 522.5-577.5g, calcium hydrogen phosphate 47.5-52.5g, 40%(ml/ml) ethanol 76-84g, magnesium stearate 6.65-7.35g.
As preferred R-1132 prescription of the present invention every ten thousand Central Plains supplementary product kinds and consumption: diphenoxylate hydrochloride 25g, atropine sulfate 0.25g, starch 160g, lactose 550g, calcium hydrogen phosphate 50g, 40%(ml/ml) ethanol 80g, magnesium stearate 7g.
The present invention also provides a kind of preparation method of R-1132, comprises the following steps:
1, supplementary material is pulverized, is sieved;
2, supplementary material weighs, mixes:
Because former medicine (diphenoxylate hydrochloride) is measured few (5% of≤total amount) in prescription, the equivalent dilution method that progressively increases is adopted to carry out in operation.Operate as follows: first take and the starch of diphenoxylate hydrochloride equal weight and former medicine mixed diluting, sieve, then the starch taking mixture equal weight mixes with it, sieves, obtain the principal agent material mixture of mix homogeneously; Take lactose, calcium hydrogen phosphate and remaining starch;
Take atropine sulfate, be dissolved in 40% ethanol (ml/ml);
3, granulate: load weighted diphenoxylate hydrochloride, lactose, calcium hydrogen phosphate and remaining starch have been mixed in principal agent material by material, in input mixer-granulator, first be dry mixed 10 ~ 15 minutes, property adds 40% ethanol (ml/ml) being dissolved with atropine sulfate prepared again, wet mixing 5 ~ 10 minutes, start and granulate at a high speed, it is that 10 ~ 12Hz makes wet granular that cutter rotating speed controls;
4, dry; Add in the feed hopper of HighefficientFluidbeddrier by the wet granular made by material, inlet temperature controls at about 80 DEG C, and leaving air temp controls about 45 DEG C.Drying time, control was 5 ~ 10 minutes, and granule to be dried confirms dried (moisture control 3% ~ 5%).Stop heating, cooling.Discharging when drop temperature about 37 DEG C.
5, granulate: by the granule Fast granulate machine granulate after oven dry, selects cylinder screen cloth, 16 ~ 18 orders.
6, always mix: the granule after each material granulate is contained in elevator and is fed in three-dimensional motion mixer, and drop into load weighted lubricant magnesium stearate mixing mixing in 10 ~ 15 minutes;
7, tabletting;
8, pack.
The technique effect of R-1132 of the present invention is: have good dissolution and content uniformity.
Detailed description of the invention
Embodiment 1 R-1132 prescription
Table 1
The preparation of embodiment 2 R-1132
1, supplementary material is pulverized, is sieved: the pulverizing of supplementary material has come by omnipotent high speed disintegrator; Sieve and use shaking screen.Sieved 80 mesh sieves of requirement vortex oscillation such as crude drug diphenoxylate hydrochloride and supplementary product starch, magnesium stearate, calcium hydrogen phosphate; Lactose adjuvant requires to pulverize sieved 80 mesh sieves of rear vortex oscillation with omnipotent high speed disintegrator;
2, weigh: first take and be fed into mixed diluting in container with the supplementary product starch of diphenoxylate hydrochloride equal weight together with former medicine, cross 80 mesh sieves, then the starch taking mixture equal weight mixes with it, cross 80 mesh sieves, obtain the mixture of mix homogeneously;
Take the adjuvant of other ormal weight again: lactose, calcium hydrogen phosphate and remaining starch;
Because atropine sulfate amount is minimum, be dissolved in 40% ethanol for subsequent use;
3, granulate: often expect that supplementary material drops in efficient wet granulator by material by load weighted; build cover; start anchor type stirring paddle; first be dry mixed 10 ~ 15 minutes; property adds 40% ethanol having dissolved atropine sulfate prepared again, wet mixing 5 ~ 10 minutes, starts and granulates at a high speed; it is 10 ~ 12Hz that cutter rotating speed controls, and makes suitable wet granular;
4, dry: add in the feed hopper of HighefficientFluidbeddrier by the wet granular made by material, inlet temperature controls at about 80 DEG C, and leaving air temp controls about 45 DEG C.Drying time, control was 5 ~ 10 minutes, and granule to be dried confirms dried (moisture control is 3% ~ 5%).Stop heating, cooling.Discharging when drop temperature about 37 DEG C;
5, granulate: by the granule Fast granulate machine granulate after oven dry, selects cylinder (16 ~ 18 order);
6, always mix: the granule after each material granulate is contained in elevator and is fed in three-dimensional motion mixer, and drop into load weighted lubricant magnesium stearate mixing 10 ~ 15 minutes;
7, tabletting;
8, pack.
The item inspection of the R-1132 that embodiment 3 is prepared according to prescription and embodiment 2 method of embodiment 1
Dissolution: dissolution medium: containing the aqueous acetic acid of 0.2mol/L; Operative installations 1, rotating speed 150rpm, 45 minutes time, detection method: mobile phase: acetonitrile: potassium dihydrogen phosphate (65:35), standard solution: compound concentration is the solution of the diphenoxylate hydrochloride standard substance of 250ug/ml, is settled to 500ml with dissolution medium, filter, chromatographic system; 210nm wavelength detecting, L11 packed column (3.9mm*30mm), flow velocity: 1.0ml/ minute, standard solution sample introduction, record chromatogram, tailing factor must not more than 1.5, relative standard deviation must not cross 2.0%, by standard solution and product to be tested sample introduction respectively, and sample size 50ul, record chromatogram, in 45 minutes, dissolution must not lower than the 75%(of labelled amount with reference to USP Method 34 editions).
Outward appearance, uniformity of dosage units: by Chinese Pharmacopoeia 2010 editions inspection
Table 2
Table 2 result shows that the present invention selects the adjuvant of specific proportioning that gained tablet can be made to obtain desirable outward appearance, dissolution and uniformity of dosage units.
Comparative example 1 changes R-1132 prescription by table 3, prepares R-1132 according to embodiment 2 method, carries out item inspection according to embodiment 3 method
Table 3
Table 3 result shows: contrast prescription 1, compared with the prescription 2 in table 1, adopts 42%(ml/ml) ethanol, the tablet hardness of extrusion is bad (being about 15N), easy loose pieces, friability 1.8%.
Contrast 2, compared with the prescription 2 in table 1, adopts 38%(ml/ml) ethanol, gained tablet hardness is excessive, bright and clean not, and dissolution declines, and average dissolution is 82%.
Contrast prescription 3 is compared with prescription 1, and change lactose into sucrose, gained tablet not only outer light is bright and clean not, and disintegrate is difficult, and dissolution is only 76%.
It can thus be appreciated that, the present invention is directed to every ten thousand diphenoxylate hydrochloride 25g, atropine sulfate 0.25g selects the ethanol of certain concentration as binding agent and select starch, lactose, calcium hydrogen phosphate can obtain desirable slice, thin piece outward appearance, desirable dissolution and uniformity of dosage units as filler gained tablet.
Comparative example 2 presses the R-1132 prescription of table 1, prepares R-1132 by the following method, carries out item inspection according to embodiment 3 method
1, supplementary material is pulverized, is sieved; (with embodiment 2)
2, weigh: first take and be fed into mixed diluting in container with the supplementary product starch of diphenoxylate hydrochloride, atropine sulfate gross weight equal weight together with diphenoxylate hydrochloride, atropine sulfate; cross 80 mesh sieves; the starch taking mixture equal weight again mixes with it; cross 80 mesh sieves, obtain the mixture of mix homogeneously; Take the adjuvant of other ormal weight again: lactose, calcium hydrogen phosphate and remaining starch;
3, granulate: often expect that supplementary material drops in efficient wet granulator by material by load weighted; build cover; start anchor type stirring paddle; first be dry mixed 10 ~ 15 minutes; property adds 40% ethanol again, wet mixing 5 ~ 10 minutes, starts and granulates at a high speed; it is 10 ~ 12Hz that cutter rotating speed controls, and makes suitable wet granular; 4 ~ 8(is with embodiment 2)
The i.e. same diphenoxylate hydrochloride of feed postition of this preparation technology atropine sulfate compared with embodiment 2, but not add after being dissolved in 40% ethanol.Obtained sheet agent content homogeneity A+1.8S, as table 4, data show, because atropine content in this prescription is low, every sheet content, at 0.03mg, adopts and directly adds hybrid mode, is difficult to mix homogeneously.
Table 4
With above-mentioned according to desirable embodiment of the present invention for enlightenment, by above-mentioned description, associated production personnel in the scope not departing from this invention technological thought, can carry out various change and amendment completely.The technical scope of this invention is not limited to the content in description, must determine its technical scope according to right.

Claims (1)

1. a R-1132, every ten thousand Central Plains supplementary product kinds and consumption: diphenoxylate hydrochloride 25g, atropine sulfate 0.25g, starch 160g, lactose 550g, calcium hydrogen phosphate 50g, 40%ml/ml ethanol 80g, magnesium stearate 7g,
The preparation method of described R-1132 is,
(1) supplementary material is pulverized, is sieved
After supplementary material is pulverized by omnipotent high speed disintegrator, with sieved 80 mesh sieves of vortex oscillation;
(2) supplementary material weighs, mixes
First take and be fed into mixed diluting in container with the supplementary product starch of diphenoxylate hydrochloride equal weight together with former medicine, cross 80 mesh sieves, then the starch taking mixture equal weight mixes with it, cross 80 mesh sieves, obtain the principal agent material mixture of mix homogeneously,
Take lactose, calcium hydrogen phosphate and remaining starch,
Take atropine sulfate, be dissolved in 40%ml/ml ethanol;
(3) granulate, load weighted lactose, calcium hydrogen phosphate and remaining starch being added mixes in principal agent material mixture, in input mixer-granulator, first be dry mixed 10 ~ 15 minutes, property adds the 40%ml/ml ethanol being dissolved with atropine sulfate prepared again, wet mixing 5 ~ 10 minutes, starts and granulates at a high speed, it is 10 ~ 12Hz that cutter rotating speed controls, and makes wet granular;
(4) dry, the wet granular made is added in the feed hopper of HighefficientFluidbeddrier by material, inlet temperature controls at 80 DEG C, leaving air temp controls 45 DEG C, and drying time, control was 5 ~ 10 minutes, and granule to be dried confirms dried, namely moisture control is 3% ~ 5%, stop heating, cooling, discharging when drop temperature 37 DEG C;
(5) granulate, by the granule Fast granulate machine granulate after oven dry, selects cylinder screen cloth, sieve number 16 ~ 18 order;
(6) always mix, the granule after each material granulate is contained in elevator and drops in three-dimensional motion mixer, and drop into load weighted lubricant magnesium stearate mixing mixing in 10 ~ 15 minutes;
(7) tabletting;
(8) pack.
CN201310003871.4A 2013-01-07 2013-01-07 R-1132 and preparation method thereof Active CN103040828B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310003871.4A CN103040828B (en) 2013-01-07 2013-01-07 R-1132 and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310003871.4A CN103040828B (en) 2013-01-07 2013-01-07 R-1132 and preparation method thereof

Publications (2)

Publication Number Publication Date
CN103040828A CN103040828A (en) 2013-04-17
CN103040828B true CN103040828B (en) 2015-12-02

Family

ID=48053840

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310003871.4A Active CN103040828B (en) 2013-01-07 2013-01-07 R-1132 and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103040828B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105503701B (en) * 2014-09-22 2018-11-13 河南鼎昌药业有限公司 A kind of recovery processing technique of the unqualified diphenoxylate hydrochloride of content
CN108904457B (en) * 2018-08-07 2021-07-20 河北君圣药业有限公司 Compound diphenoxylate tablet and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1589140A (en) * 2001-09-18 2005-03-02 格吕伦塔尔有限公司 Combination of selected opioids with muscarine antagonists for treating urinary incontinence

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1589140A (en) * 2001-09-18 2005-03-02 格吕伦塔尔有限公司 Combination of selected opioids with muscarine antagonists for treating urinary incontinence

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
高效液相色谱法同时测定复方地芬诺酯片中两组分含量;何建锋等;《中国药业》;20101231;第19卷(第5期);第22-23页 *

Also Published As

Publication number Publication date
CN103040828A (en) 2013-04-17

Similar Documents

Publication Publication Date Title
Hebbink et al. Application of lactose in the pharmaceutical industry
CA2820371C (en) Medicated particulate animal feed supplements and methods of preparation
CN103040828B (en) R-1132 and preparation method thereof
CN100396278C (en) Medicinal micro pill core and its preparing method
CN104306344B (en) A kind of Azilsartan tablet and preparation technology thereof
CN103040774B (en) Granulating and coating process of esomeprazole magnesium contained in esomeprazole magnesium enteric-coated tablet
CN103637994B (en) A kind of premixing auxiliary material and preparation technology thereof
WO2012027968A1 (en) Panaxatriol saponins enteric pellet, capsule comprising same and method for preparing same
CN105125575A (en) Preparation method of drug for hyperphosphatemia
CN108066430A (en) A kind of sweet wormwood Changshan effervescence granular for animals and preparation method thereof
CN104840427A (en) Pharmaceutical composition containing montelukast sodium
CN104324012B (en) A kind of pet actively searches for food expelling parasite piece
CN114288259B (en) Quick-release preparation of vitamin B2 and preparation method thereof
CN102379855A (en) Glimepiride dispersible tablet and preparation method thereof
CN101664512B (en) Method for preparing traditional Chinese medicine preparation containing herba sarcandrae extracts
CN102106824B (en) Eszopiclone solid preparation and preparation method thereof
CN102512691A (en) Telmisartan composition and application thereof
CN104352465B (en) Prucalopride succinate pharmaceutical composition free of silicon dioxide and preparation method of prucalopride succinate pharmaceutical composition
CN102416004A (en) Glimepiride tablets and preparation method thereof
CN106176643A (en) Clobazam sheet and preparation method
CN103181905A (en) Process for preparing pramipexole dihydrochloride tablets
CN102106805B (en) Cymipristone solid preparation and preparation methods thereof
CN108904457A (en) R-1132 and preparation method thereof
CN104740640B (en) A kind of crystal modification thing for improving chemical drugs material powder property and preparation method thereof
CN108125917A (en) A kind of method of the preparation of mitiglinide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant